Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc.

LYEL
Lyell Immunopharma, Inc.US flagNASDAQ Global Select
12.57
USD
-2.32
- -
293.31MMarket Cap

Lyell Immunopharma, Inc. (LYEL) Stock Splits

Learn about Lyell Immunopharma, Inc.'s most recent 1-for-20 basis stock split on June 02, 2025. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Lyell Immunopharma, Inc.'s most recent stock split

Split Date: 2025-06-02
Split Ratio: 1:20
Price Before Split: $0.41
Price After Split: $0.02

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 20.00 times fewer shares (a 1:20 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Lyell Immunopharma, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2025-06-021:20Yes$0.41$0.02

About Lyell Immunopharma, Inc.

Company overview and industry information

Lyell Immunopharma, Inc. (LYEL) operates in the Biotechnology industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Lyell Immunopharma, Inc. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.